STVN
Stevanato Group SpA
NYSE: STVN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$15.53
-1.71% today
Updated 2026-11-16
Market cap
$3.70B
P/E ratio
22.93
P/S ratio
2.96x
EPS (TTM)
$0.59
Dividend yield
—
52W range
$12 – $24
Volume
0.7M
Stevanato Group SpA (STVN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$15.53
12-Month target
$14.34
2030 Target
—
Intrinsic (DCF)
$48.58
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.8B | $1.0B | $1.1B | $1.1B | $1.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 22.93x (capped 25x) · Margin: 11.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.